Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.72
+0.89 (4.08%)
At close: Feb 20, 2026, 4:00 PM EST
22.28
-0.44 (-1.94%)
After-hours: Feb 20, 2026, 7:20 PM EST
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.19 billion as of February 20, 2026. Its market cap has decreased by -47.71% in one year.
Market Cap
2.19B
Enterprise Value
2.71B
1-Year Change
-47.71%
Ranking
Category
Stock Price
$22.72
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.19B, an increase of 84.28%. That is a compound annual growth rate of 5.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 2.20B | -1.06% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.07B |
| Dianthus Therapeutics | 2.05B |
| Nektar Therapeutics | 2.05B |
| Harmony Biosciences Holdings | 2.03B |
| Nuvation Bio | 1.98B |
| Sarepta Therapeutics | 1.93B |
| MBX Biosciences | 1.90B |
| Vericel | 1.89B |